- Stifel 2016 Healthcare Conference on Wednesday, November 16, 2016 in New York, NY
- 28 th Annual Piper Jaffray Healthcare Conference on Tuesday, November 29, 2016 in New York, NY
Investors focus on a drug's efficacy and safety. Much less time is spent considering the importance of manufacturing, even though it is a vital step in the drug approval process.
When Biogen reports first-quarter earnings Tuesday, investors will be looking to see if Spinraza sales match or exceed $16 million consensus.
Jim Cramer is bullish on General Dynamics, Raytheon, and Northrop Grumman.
Jim Cramer looks to the companies that are really making it work for investors: AXP, GOOGL, FB.